The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 13, 2017

Filed:

Jul. 17, 2013
Applicant:

The Regents of the University of Michigan, Ann Arbor, MI (US);

Inventors:

Jason E. Gestwicki, Moss Beach, CA (US);

Kathryn McMenimen, South Hadley, MA (US);

Leah Makley, San Francisco, CA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/56 (2006.01); A61K 31/575 (2006.01); A61K 47/48 (2006.01); A61K 31/045 (2006.01); G01N 33/68 (2006.01); C07J 9/00 (2006.01); C12Q 1/34 (2006.01); B82Y 5/00 (2011.01); A61K 9/00 (2006.01); G01N 21/64 (2006.01);
U.S. Cl.
CPC ...
A61K 31/575 (2013.01); A61K 9/0048 (2013.01); A61K 31/045 (2013.01); A61K 47/48969 (2013.01); B82Y 5/00 (2013.01); C07J 9/00 (2013.01); C12Q 1/34 (2013.01); G01N 21/6428 (2013.01); G01N 33/68 (2013.01); G01N 2201/10 (2013.01); G01N 2333/4709 (2013.01); G01N 2500/20 (2013.01);
Abstract

The invention provides inhibitors of α-crystallin aggregation and methods of using α-crystallin aggregation inhibitors to, e.g., treat or prevent cataracts in a subject having or at risk of developing cataracts. The invention further provides high throughput methods of screening compounds for modulation of protein thermal stability, the method comprising contacting a protein with each of a plurality of test compounds; and (b) measuring the melting transition (T) of the protein in the presence of each of the plurality of test compounds, wherein a compound that decreases or increases the apparent Tby at least 2 standard deviations is identified as a pharmacological protein chaperone.


Find Patent Forward Citations

Loading…